Graham Emslie

Summary

Affiliation: University of Texas Southwestern Medical Center
Country: USA

Publications

  1. pmc Treatment for Adolescents with Depression Study (TADS): safety results
    Graham Emslie
    UT Southwestern Medical Centre at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1440-55. 2006
  2. ncbi request reprint Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)
    Betsy Kennard
    UT Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1404-11. 2006
  3. pmc Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder
    Rongrong Tao
    University of Texas Southwestern Medical Center at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 48:71-8. 2009
  4. doi request reprint Attention training for school-aged children with ADHD: results of an open trial
    Leanne Tamm
    UT Southwestern Medical Center, Dallas, TX, 75390 8589, USA
    J Atten Disord 14:86-94. 2010
  5. pmc Assessment of safety and long-term outcomes of initial treatment with placebo in TADS
    Betsy D Kennard
    University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    Am J Psychiatry 166:337-44. 2009
  6. ncbi request reprint Hopelessness and suicidal ideation among adolescents in two cultures
    Sunita Mahtani Stewart
    Psychiatry Department, University of Texas Southwestern Medical Center at Dallas, TX 75390 8589, USA
    J Child Psychol Psychiatry 46:364-72. 2005
  7. ncbi request reprint Pharmacological management of treatment-resistant pediatric depression
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:198-200. 2005
  8. pmc Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial
    David Brent
    University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    JAMA 299:901-13. 2008
  9. ncbi request reprint Acute time to response in the Treatment for Adolescents with Depression Study (TADS)
    Christopher Kratochvil
    University of Nebraska Medical Center NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 45:1412-8. 2006
  10. ncbi request reprint An exploratory factor analysis of the children's depression rating scale-revised
    Ying Guo
    Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    J Child Adolesc Psychopharmacol 16:482-91. 2006

Detail Information

Publications15

  1. pmc Treatment for Adolescents with Depression Study (TADS): safety results
    Graham Emslie
    UT Southwestern Medical Centre at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1440-55. 2006
    ..To compare the rates of physical, psychiatric, and suicide-related events in adolescents with MDD treated with fluoxetine alone (FLX), cognitive-behavioral therapy (CBT), combination treatment (COMB), or placebo (PBO)...
  2. ncbi request reprint Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS)
    Betsy Kennard
    UT Southwestern Medical Center, Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 45:1404-11. 2006
    ....
  3. pmc Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder
    Rongrong Tao
    University of Texas Southwestern Medical Center at Dallas, TX 75390 8589, USA
    J Am Acad Child Adolesc Psychiatry 48:71-8. 2009
    ..In a prospective open-label fluoxetine study, we investigate indicators of acute treatment response and remission...
  4. doi request reprint Attention training for school-aged children with ADHD: results of an open trial
    Leanne Tamm
    UT Southwestern Medical Center, Dallas, TX, 75390 8589, USA
    J Atten Disord 14:86-94. 2010
    ....
  5. pmc Assessment of safety and long-term outcomes of initial treatment with placebo in TADS
    Betsy D Kennard
    University of Texas Southwestern Medical Center at Dallas, 75390 8589, USA
    Am J Psychiatry 166:337-44. 2009
    ....
  6. ncbi request reprint Hopelessness and suicidal ideation among adolescents in two cultures
    Sunita Mahtani Stewart
    Psychiatry Department, University of Texas Southwestern Medical Center at Dallas, TX 75390 8589, USA
    J Child Psychol Psychiatry 46:364-72. 2005
    ..This study examines the cross-sectional and longitudinal associations among cognitive variables, depressive symptoms and suicidal ideation in Hong Kong Chinese and Caucasian American adolescents...
  7. ncbi request reprint Pharmacological management of treatment-resistant pediatric depression
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:198-200. 2005
  8. pmc Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial
    David Brent
    University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    JAMA 299:901-13. 2008
    ..There are no data to guide clinicians on subsequent treatment strategy...
  9. ncbi request reprint Acute time to response in the Treatment for Adolescents with Depression Study (TADS)
    Christopher Kratochvil
    University of Nebraska Medical Center NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 45:1412-8. 2006
    ..To examine the time to response for both pharmacotherapy and psychotherapy in the Treatment for Adolescents with Depression Study (TADS)...
  10. ncbi request reprint An exploratory factor analysis of the children's depression rating scale-revised
    Ying Guo
    Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
    J Child Adolesc Psychopharmacol 16:482-91. 2006
    ..After controlling for gender, the adolescents had more severe depression in terms of observed depressive mood, anhedonia, and somatic symptoms. After controlling for age groups, girls had higher scores for reported depressive mood...
  11. ncbi request reprint Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    J Child Adolesc Psychopharmacol 16:11-24. 2006
    ..The authors have concluded that SSRIs -- in particular, fluoxetine -- do have a role in the treatment of pediatric depression...
  12. ncbi request reprint Sleep microarchitecture in childhood and adolescent depression: temporal coherence
    Roseanne Armitage
    Sleep and Chronophysiology Laboratory, Department of Psychiatry, University of Michigan, Ann Arbor 48105, USA
    Clin EEG Neurosci 37:1-9. 2006
    ..In conclusion, early onset depression is associated with a reduction in synchronization of sleep EEG rhythms that shows a differential maturational course in boys and girls...
  13. ncbi request reprint ACNP Task Force report on SSRIs and suicidal behavior in youth
    J John Mann
    Columbia University New York State Psychiatric Institute, New York, NY 10032, USA
    Neuropsychopharmacology 31:473-92. 2006
    ....
  14. ncbi request reprint Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial
    Daniel A Geller
    Harvard Medical School, Boston, MA 02114, USA
    J Am Acad Child Adolesc Psychiatry 43:1387-96. 2004
    ..To assess the efficacy and safety of paroxetine for the treatment of pediatric obsessive-compulsive disorder...
  15. ncbi request reprint Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
    Daniel A Geller
    Obsessive Compulsive Disorder Program, Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Child Adolesc Psychopharmacol 13:S19-29. 2003
    ..To examine the influence of psychiatric comorbidity on response and relapse rates in children and adolescents treated with paroxetine for obsessive-compulsive disorder (OCD)...